Related Experiment Video
Updated: Jan 12, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Challenges in assessing bone health in early infancy: a narrative review of existing technologies
Giorgia Pepe1, Letteria Anna Morabito1, Domenico Corica1
1Department of Human Pathology of Adulthood and Childhood, University of Messina, Messina, Italy.
Insights
New methods are needed to assess bone mineral density (BMD) in infants due to a lack of guidelines. Radiofrequency Echographic Multi-Spectrometry (REMS) shows promise for infant bone health assessment.
Area of Science:
- Pediatrics
- Radiology
- Biophysics
Background:
- Lack of established guidelines for diagnosing and managing low bone mineral density (BMD) in infants.
- Infants are susceptible to risk factors like maternal vitamin D deficiency, preterm birth, and low birth weight, necessitating bone health monitoring.
- Current BMD assessment methods (biochemical markers, DXA, QUS) have limitations in newborns and infants.
Purpose of the Study:
- To highlight the need for new methodologies for assessing bone health in infants.
- To introduce Radiofrequency Echographic Multi-Spectrometry (REMS) as a promising tool for infant BMD assessment.
- To discuss the potential of REMS for mass screening strategies in sensitive populations.
Main Methods:
- Review of current diagnostic tools for infant BMD, including biochemical markers, DXA, and QUS.
- Introduction of REMS technology, emphasizing its radiation-free nature, ease of use, cost-effectiveness, sensitivity, specificity, and reproducibility.
- Discussion of the limitations of existing methods and the advantages of REMS.
Main Results:
- REMS is identified as a potentially superior technique for screening and monitoring BMD in newborns and infants.
- REMS offers advantages over traditional methods due to its safety profile and performance characteristics.
- A significant gap exists as validated REMS reference cut-offs for pediatric populations are currently unavailable.
Conclusions:
- REMS technology presents a promising, radiation-free approach for assessing bone mineral density in infants.
- Further longitudinal studies are essential to establish REMS reference standards and develop diagnostic algorithms for pediatric bone health.
- Integrated approaches combining biochemical and instrumental data are needed for effective diagnosis and management of low BMD in infants.
Abstract:
To date, no shared guidelines have been approved for the diagnosis and management of low bone mineral density (BMD), especially in early infancy. Therefore, there is an increasing demand for new methodologies to allow the assessment of bone health status in this specific cohort, which is exposed to several risk factors (e.g. maternal vitamin D deficiency, pregnancy-associated diseases, preterm birth and comorbidities, low birth weight, intrauterine growth restriction). Currently, the assessment of BMD in newborn and infants relies mainly on serum and urinary biochemical markers, in association with several technologies to measure bone mineral content, such as dual-energy X-ray absorptiometry (DXA) and quantitative ultrasound (QUS) being traditionally used, despite many limitations. More recently, Radiofrequency Echographic Multi-Spectrometry (REMS) emerged as a promising tool in clinical practice for screening and monitoring BMD. Due to the radiation-free technology, an extremely ease of use, low costs, an excellent degree of sensitivity, specificity, and reproducibility, REMS technology has proven to be the gold standard technique in sensitive populations such as pregnant women, newborns and infants, allowing mass extended screening strategies. However, to date no validate cut-off reference for REMS in paediatric age are available. Future longitudinal studies on REMS methodology are needed to build reference standards and new shared algorithms, combining biochemical and instrumental data, for the diagnosis, management and treatment of decreased BMD before and after birth.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Bone Remodeling

